Self-propelled micro/nanobots: A new insight into precisely targeting cancerous cells through intelligent and deep cancer penetration.
Cancer therapy
Drug delivery
Nanostructures
Neoplasms
Self-propelled micro/nanomotors
Journal
European journal of pharmacology
ISSN: 1879-0712
Titre abrégé: Eur J Pharmacol
Pays: Netherlands
ID NLM: 1254354
Informations de publication
Date de publication:
05 Jul 2022
05 Jul 2022
Historique:
received:
23
02
2022
revised:
03
05
2022
accepted:
04
05
2022
pubmed:
15
5
2022
medline:
9
6
2022
entrez:
14
5
2022
Statut:
ppublish
Résumé
Cancer overlooks are globally one of the most dangerous and life-threatening tribulations. While significant advances have been made in the targeted delivery of anti-cancer medications over the last few years, several challenges, such as low efficacy and strong toxic effects, remain to be addressed. Micro/nanomotors have been thoroughly studied for both effective cancer detection and treatment, as demonstrated by significant advancements in the architecture of smart and functional micro/nanomotor biomedical systems. Able to self-propelled within fluid media, micro/nanomotors have attractive vehicles to maximize the efficacy of tumor delivery. Here, we present the current developments in the delivery, detection, and imaging-guided treatment of micro/nanomotors in the clinical field, including cancer-related specific targeted drug delivery, and then discuss the barriers and difficulties encountered by micro/nanomotors throughout the medical process. Furthermore, this paper addresses the potential growth of micro/nanomotors for medical applications, and sets out the current drawbacks and future research directions for more advancement.
Identifiants
pubmed: 35568064
pii: S0014-2999(22)00272-2
doi: 10.1016/j.ejphar.2022.175011
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
175011Informations de copyright
Copyright © 2022 Elsevier B.V. All rights reserved.